Expon I
Expon I is a venture capital firm based in Luxembourg, established in 2015. It focuses on investing in innovative companies across various sectors, including cybersecurity, fintech, big data, digital health, and next-generation media. The firm seeks opportunities that demonstrate the potential for significant growth and positive societal impact, specifically targeting businesses in Europe, North America, and Israel. By concentrating on sectors such as software, media, mobile technologies, and communication networks, Expon I aims to support and scale transformative ideas that align with its investment philosophy.
HelloBetter
Venture Round in 2025
HelloBetter is a pioneering company in the field of digital therapeutics for mental health, founded in 2015 as a university spin-off by renowned research psychologists. Headquartered in Hamburg, Germany, with an additional office in Berlin, HelloBetter offers a range of online psychological training programs aimed at managing conditions such as stress, depression, anxiety, panic disorders, and sleep disturbances. The company's innovative approach has led to the approval of six of its online therapy programs as prescription digital therapeutics under the German DiGA framework, allowing them to be accessed at no cost by over 73 million people in Germany. With a total of ten digital therapeutics evaluated in numerous randomized controlled trials, HelloBetter is committed to making evidence-based mental health care accessible worldwide. The company is actively expanding its reach beyond the DACH region, supported by a recent funding round.
HelloBetter
Series A in 2023
HelloBetter is a pioneering company in the field of digital therapeutics for mental health, founded in 2015 as a university spin-off by renowned research psychologists. Headquartered in Hamburg, Germany, with an additional office in Berlin, HelloBetter offers a range of online psychological training programs aimed at managing conditions such as stress, depression, anxiety, panic disorders, and sleep disturbances. The company's innovative approach has led to the approval of six of its online therapy programs as prescription digital therapeutics under the German DiGA framework, allowing them to be accessed at no cost by over 73 million people in Germany. With a total of ten digital therapeutics evaluated in numerous randomized controlled trials, HelloBetter is committed to making evidence-based mental health care accessible worldwide. The company is actively expanding its reach beyond the DACH region, supported by a recent funding round.
HelloBetter
Series A in 2022
HelloBetter is a pioneering company in the field of digital therapeutics for mental health, founded in 2015 as a university spin-off by renowned research psychologists. Headquartered in Hamburg, Germany, with an additional office in Berlin, HelloBetter offers a range of online psychological training programs aimed at managing conditions such as stress, depression, anxiety, panic disorders, and sleep disturbances. The company's innovative approach has led to the approval of six of its online therapy programs as prescription digital therapeutics under the German DiGA framework, allowing them to be accessed at no cost by over 73 million people in Germany. With a total of ten digital therapeutics evaluated in numerous randomized controlled trials, HelloBetter is committed to making evidence-based mental health care accessible worldwide. The company is actively expanding its reach beyond the DACH region, supported by a recent funding round.
HelloBetter
Seed Round in 2021
HelloBetter is a pioneering company in the field of digital therapeutics for mental health, founded in 2015 as a university spin-off by renowned research psychologists. Headquartered in Hamburg, Germany, with an additional office in Berlin, HelloBetter offers a range of online psychological training programs aimed at managing conditions such as stress, depression, anxiety, panic disorders, and sleep disturbances. The company's innovative approach has led to the approval of six of its online therapy programs as prescription digital therapeutics under the German DiGA framework, allowing them to be accessed at no cost by over 73 million people in Germany. With a total of ten digital therapeutics evaluated in numerous randomized controlled trials, HelloBetter is committed to making evidence-based mental health care accessible worldwide. The company is actively expanding its reach beyond the DACH region, supported by a recent funding round.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.